← Eichor
Study identifier: NCT05498584 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Targeting LOXL2 and Cardiac Fibrosis for Post-acute Heart Failure Treatment- A Prospective Study

Condition: Heart Failure; With Decompensation  ·  Sponsor: Chang Gung Memorial Hospital

PhaseN/A
Planned participants130
Who can joinAll sexes, 20 Years to 100 Years
Healthy volunteersNo

About this study

A previous study demonstrated that a multidisciplinary cardiac rehabilitation (CR) program was associated with reduced medium- to long-term all-cause mortality in a retrospective propensity score-matched study. The investigators will further investigate the predictors including LOXl2, cardiac MRI, and endothelial function that will benefit from a successful CR.

This description comes directly from the study's public registry record.

Talk to the study team

Hsin-Yen Tsai  ·  +886929610850  ·  milktea588@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Chang Gung Memorial Hospital Heart Failure CenterKaohsiung City, TaiwanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05498584